source
- UniQure shares tumble as Huntington's gene therapy shows reduced benefit over timeUniQure announced new follow-up data from its experimental gene therapy for Huntington's disease, indicating the treatment's effect may diminish with longer observation. The additional year of dat…
- ARCH Venture Partners and Population Health Partners launch China-based sleep-disorder startup SomniveraARCH Venture Partners and Population Health Partners have teamed up again to create a new China-focused biotech, Somnivera, aimed at developing therapies for sleep disorders. The partnership follo…